Get the Stockscreener App
1.59
0.00%
0.00
Pharmacyte Biotech Inc stock is traded at $1.59, with a volume of 8,908.
It is up +0.00% in the last 24 hours and down -4.22% over the past month.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
See More
Previous Close:
$1.59
Open:
$1.56
24h Volume:
8,908
Relative Volume:
0.64
Market Cap:
$10.45M
Revenue:
-
Net Income/Loss:
$22.68M
P/E Ratio:
3.00
EPS:
0.53
Net Cash Flow:
$-1.94M
1W Performance:
-0.93%
1M Performance:
-4.22%
6M Performance:
-16.59%
1Y Performance:
-28.22%
1-Day Range:
$1.48
$1.565
1-Week Range:
$1.4601
$1.65
52-Week Range:
$1.39
$2.58
Pharmacyte Biotech Inc Stock (PMCB) Company Profile
Name
Pharmacyte Biotech Inc
Sector
Industry
Phone
(917) 595.2850
Address
23046 AVENIDA DE LA CARLOTA, SUITE 600, LAGUNA HILLS
Compare PMCB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 2.24 | 0 | 0 | 0 | 0 | 0.00 | |
PSNYW
Polestar Automotive Holding Uk
|
0.1901 | 409.20M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.70 | 372.90M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
0.4356 | 278.60M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.235 | 96.03M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
4.00 | 52.42M | 0 | 0 | 0 | 0.00 |
Pharmacyte Biotech Inc Stock (PMCB) Latest News
Pancreatic Cancer Treatment Market to Surge to USD 10.2 - GlobeNewswire
PharmaCyte Biotech (OTCMKTS:PMCBD) Stock Price Up 0.1% – What’s Next? - Defense World
Global Ascites Market Size and Trends, Forecast 2025-2035: Unlocking Key Insights for Strategic Growth – Custom Market Insights - BioSpace
PharmaCyte Biotech, Inc. (NASDAQ:PMCB) Shares Sold by Geode Capital Management LLC - Defense World
PharmaCyte Biotech (OTCMKTS:PMCBD) Trading 1.5% Higher – Time to Buy? - Defense World
PharmaCyte Biotech (OTCMKTS:PMCBD) Stock Price Up 1.5% – Still a Buy? - Defense World
Comparing Vaxcyte (NASDAQ:PCVX) & PharmaCyte Biotech (OTCMKTS:PMCBD) - Defense World
Financial Comparison: Coeptis Therapeutics (NASDAQ:COEP) & PharmaCyte Biotech (NASDAQ:PMCB) - Defense World
PharmaCyte Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2024 - Marketscreener.com
PharmaCyte Biotech Inc. (PMCB) reports earnings - Quartz
CXApp (NASDAQ:CXAI) & Aware (NASDAQ:AWRE) Financial Contrast - Defense World
Jasper Therapeutics (NASDAQ:JSPR) versus PharmaCyte Biotech (OTCMKTS:PMCBD) Head to Head Comparison - Defense World
Zacks Research Issues Positive Estimate for SRPT Earnings - Defense World
T-Mobile US, Inc. to Present at the Wells Fargo TMT Summit - Business Wire
Silence Therapeutics to Participate in Fireside Chat at Piper Sandler 36th Annual Healthcare Conference - Business Wire
PSTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Poseida Therapeutics, Inc. Is Fair to Shareholders - Business Wire
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. Announces Completion of Liquidation - Business Wire
HubSpot to Present at the Wells Fargo Technology Conference - Business Wire
MTCH Investors Have Opportunity to Lead Match Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
SUM Investors Have the Opportunity to Join Investigation of Summit Materials, Inc. with the Schall Law Firm - Business Wire
Glancy Prongay & Murray LLP Announces Investigation of Triumph Group, Inc. (TGI) - Business Wire
Glancy Prongay & Murray LLP Announces Investigation of TruBridge, Inc. (f//k/a Computer Programs and Systems, Inc.) (TBRG) - Business Wire
Vir Biotechnology to Participate in the 7th Annual Evercore ISI HealthCONx Conference - Business Wire
EMCOR Group, Inc. to Participate at the UBS Global Industrials and Transportation Conference - Business Wire
Rallybio to Provide Update on RLYB116 Program, an Innovative Subcutaneously Injected C5 Inhibitor - Business Wire
Shareholder Alert: Ademi LLP Investigates Whether Summit Materials, Inc. is Obtaining a Fair Price for its Public Shareholders - Business Wire
INNOVID INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Innovid Corp.CTV - Business Wire
Excelerate Energy to Participate at Capital One Securities Energy Conference - Business Wire
Community Health Systems Announces Definitive Agreement to Sell ShorePoint Health System in Florida - Business Wire
Savara Announces New Employment Inducement Grant - Business Wire
Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference - Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Metagenomi, Inc. (MGX) - Business Wire
Vena Recognized as a Challenger in the 2024 Gartner® Magic Quadrant™ for Financial Planning Software - Business Wire
California American Water Relocates Infrastructure to Facilitate Fort Ord Regional Trail and Greenway Through Del Rey Oaks - Business Wire
Drive Shack Inc. Announces Release of Third Quarter Financial Results and Postponement of Special Meeting - Business Wire
REV Group to Release Fourth Quarter 2024 Earnings and Host 2024 Investor Day on Wednesday, December 11, 2024 - Business Wire
OutKick Delivers Massive Growth Month Over Month and Year Over Year in October 2024 - Business Wire
Ooma to Attend the Northland Capital Markets Growth Conference (Virtual) - Business Wire
BERRY GLOBAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Berry Global Group, Inc.BERY - Business Wire
PIEDMONT LITHIUM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Piedmont Lithium Inc.PLL - Business Wire
ELF Investors Have Opportunity to Join e.l.f. Beauty, Inc. Securities Fraud Investigation with the Schall Law Firm - Business Wire
V Investors Have Opportunity to Lead Visa Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
Medical Properties Trust Declares Regular Quarterly Dividend - Business Wire
T-Mobile Declares Quarterly Cash Dividend - Business Wire
NIKE, Inc. Announces Second Quarter Fiscal 2025 Earnings and Conference Call - Business Wire
Travel + Leisure Co. to Present at the Barclays Eat, Sleep, Play, Shop Conference and the Morgan Stanley Global Consumer & Retail Conference - Business Wire
UGI Declares Common Dividend - Business Wire
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences - Business Wire
California Homebuilding Foundation Announces Class of 2025 Inductees for 40th Annual Hall of Fame Gala - Business Wire
Consensus Cloud Solutions Recognized Among Top 100 Healthcare Technology Companies by The Healthcare Technology Report - Business Wire
Tyler Technologies’ Plano Office Named a Top Workplace in North Texas - Business Wire
Pharmacyte Biotech Inc Stock (PMCB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.59%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):